Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition. [electronic resource]
Producer: 20011101Description: 1151-9 p. digitalISSN:- 0271-678X
- Antiparkinson Agents -- therapeutic use
- Apomorphine -- pharmacology
- Dopamine -- metabolism
- Female
- Functional Laterality
- Humans
- Male
- Models, Biological
- Parkinson Disease -- diagnostic imaging
- Presynaptic Terminals -- diagnostic imaging
- Raclopride -- pharmacokinetics
- Synapses -- drug effects
- Tomography, Emission-Computed
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.